Literature DB >> 1700072

Developmental expression of HNK-1-reactive antigens in the rat cerebellum and localization of sulfoglucuronyl glycolipids in molecular layer and deep cerebellar nuclei.

N Prasadaro1, O Koul, S A Tobet, D K Chou, F B Jungalwala.   

Abstract

Monoclonal antibody HNK-1-reactive carbohydrate epitope is expressed on proteins, proteoglycans, and sulfoglucuronyl glycolipids (SGGLs). The developmental expression of these HNK-1-reactive antigens was studied in rat cerebellum. The expression of sulfoglucuronyl lacto-N-neotetraosylceramide (SGGL-1) was biphasic with an initial maximum at postnatal day one (PD 1), followed by a second rise in the level at PD 20. The level of sulfoglucuronyl lacto-N-norhexaosyl ceramide (SGGL-2) in cerebellum was low until PD 15 and then increased to a plateau at PD 20. The levels of SGGLs increased during postnatal development of the cerebellum, contrary to their diminishing expression in the cerebral cortex. The expression of HNK-1-reactive glycoproteins decreased with development of the rat cerebellum from PD 1. Several HNK-1-reactive glycoproteins with apparent molecular masses between 150 and 325 kDa were visualized between PD 1 and PD 10. However, beyond PD 10, only two HNK-1-reactive bands at 160 and 180 kDa remained. The latter appeared to be neural cell adhesion molecule, N-CAM-180. A diffuse HNK-1-reactive band seen at the top of polyacrylamide electrophoretic gels was due mostly to proteoglycans. This band increased in its reactivity to HNK-1 between PD 15 and PD 25 and then decreased in the adult cerebellum. The lipid antigens were shown by two complementary methodologies to be localized primarily in the molecular layer and deep cerebellar nuclei as opposed to the granular layer and white matter. A fixation procedure which eliminates HNK-1-reactive epitope on glycoproteins and proteoglycans, but does not affect glycolipids, allowed selective immunoreactivity in the molecular layer and deep cerebellar nuclei.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700072     DOI: 10.1111/j.1471-4159.1990.tb05791.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Association of the HNK-1 epitope with 5'-nucleotidase from Torpedo marmorata (electric ray) electric organ.

Authors:  M Vogel; H J Kowalewski; H Zimmermann; A Janetzko; R U Margolis; H E Wollny
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

2.  Regulation of sulfoglucuronyl glycolipid synthesis in the developing rat sciatic nerve.

Authors:  D K Chou; F B Jungalwala
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

Review 3.  Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system--a review.

Authors:  F B Jungalwala
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

4.  The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin.

Authors:  L K Needham; R L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

5.  Expression of neolactoglycolipids: sialosyl-, disialosyl-, O-acetyldisialosyl- and fucosyl- derivatives of neolactotetraosyl ceramide and neolactohexaosyl ceramide in the developing cerebral cortex and cerebellum.

Authors:  D K Chou; Y Suzuki; F B Jungalwala
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

Review 6.  The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy.

Authors:  Toshio Ariga
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

7.  Carbohydrate recognition in the peripheral nervous system: a calcium-dependent membrane binding site for HNK-1 reactive glycolipids potentially involved in Schwann cell adhesion.

Authors:  L K Needham; R L Schnaar
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.